AJR Am J Roentgenol
- SCHMITT JE, Smerconish S
Beyond the AJR: Demystifying COVID-19-Related Brain Fog With Perfusion MRI.
AJR Am J Roentgenol. 2025 May 21. doi: 10.2214/AJR.25.32998.
Br J Anaesth
- WELLER JM, Long J, Moore M, Henderson K, et al
Effects of a national team training intervention for operating theatre teams on
patient and staff outcomes: a stepped-wedge cluster-randomised trial and
mixed-methods study.
Br J Anaesth. 2025 May 16:S0007-0912(25)00230-2. doi: 10.1016/j.bja.2025.
Clin Infect Dis
- NADIG N, Bhimraj A, Cawcutt K, Chiotos K, et al
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of
America on the Treatment and Management of COVID-19: Vilobelimab.
Clin Infect Dis. 2025 May 22:ciaf235. doi: 10.1093.
Int J Infect Dis
- HUANG Q, Kang L, Wei X, Gong C, et al
Epidemiology and genetic diversity of common human coronaviruses in Beijing,
2015-2023: A prospective multicenter study.
Int J Infect Dis. 2025 May 14:107926. doi: 10.1016/j.ijid.2025.107926.
Intensive Care Med
- CARLET J, Payen D, Singer M
A critical assessment of corticosteroid trials for hospitalised patients with
SARS-CoV-2 disease.
Intensive Care Med. 2025 May 23. doi: 10.1007/s00134-025-07878.
J Infect
- BREUER J, Drysdale M, Walker J, Han J, et al
Monitoring the Emergence of Resistance With Sotrovimab in Immunocompromised
Patients With COVID-19: LUNAR Study.
J Infect. 2025 May 19:106510. doi: 10.1016/j.jinf.2025.106510.
- QI K, Chen J, Ma X, Li D, et al
Novel Coronaviruses Identified in Livestock: The Urgent Need to Enhance
Coronavirus Surveillance to Mitigate Zoonotic Risks.
J Infect. 2025 May 16:106512. doi: 10.1016/j.jinf.2025.106512.
J Med Virol
- JANOFF EN, Shih MC, Donskey C, Belitskaya-Levy I, et al
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among
Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and
Efficacy Studies-1 (VA CURES-1).
J Med Virol. 2025;97:e70349.
- KANG J, Park J, Son Y, Kim HJ, et al
Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in
Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based
Cohort Study in South Korea.
J Med Virol. 2025;97:e70406.
- CHEN Q, Tan K
Neurovascular Barrier Protection in COVID-19: Emerging Therapeutic Targets From
SARS-CoV-2 Pathogenesis.
J Med Virol. 2025;97:e70413.
J Virol
- QIAN Q, Zhao S-s, Yang L, Xing G, et al
Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike
protein by antagonizing its degradation via chaperone-mediated autophagy to
facilitate viral proliferation.
J Virol. 2025 May 22:e0034725. doi: 10.1128/jvi.00347.
- WANG Y, Cheng Y, Wang S, Liu D, et al
Unraveling the cross-talk between a highly virulent PEDV strain and the host via
single-cell transcriptomic analysis.
J Virol. 2025 May 21:e0055525. doi: 10.1128/jvi.00555.
- BEAN DJ, Liang YM, Avila F, He X, et al
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding
antibodies.
J Virol. 2025 May 19:e0055025. doi: 10.1128/jvi.00550.
Lancet Infect Dis
-
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in
patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled,
open-label, platform trial.
Lancet Infect Dis. 2025 May 15:S1473-3099(25)00093.
- LUI GCY, Hui DSC
Revisiting oral antivirals for COVID-19 in the hospital setting.
Lancet Infect Dis. 2025 May 15:S1473-3099(25)00169.
N Engl J Med
- PRASAD V, Makary MA
An Evidence-Based Approach to Covid-19 Vaccination.
N Engl J Med. 2025 May 20. doi: 10.1056/NEJMsb2506929.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016